134. Vogelbaum M. A., Brown P. D., Messersmith H., Brastianos P. K., Burri S., Cahill D., Dunn I. F., Gaspar L. E., Gatson N. T. N., Gondi V., Jordan J. T., Lassman A. B., Maues J., Mohile N., Redjal N., Stevens G., Sulman E., van den Bent M., Wallace H. J., Weinberg J. S., Zadeh G., Schiff D. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline // J Clin Oncol. ‒ 2022. ‒ T. 40, № 5. ‒ C. 492-516.
135. Gondi V., Bauman G., Bradfield L., Burri S. H., Cabrera A. R., Cunningham D. A., Eaton B. R., Hattangadi-Gluth J. A., Kim M. M., Kotecha R., Kraemer L., Li J., Nagpal S., Rusthoven C. G., Suh J. H., Tome W. A., Wang T. J. C., Zimmer A. S., Ziu M., Brown P. D. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline // Pract Radiat Oncol. ‒ 2022. ‒ T. 12, № 4. ‒ C. 265-282.
136. Le Rhun E., Guckenberger M., Smits M., Dummer R., Bachelot T., Sahm F., Galldiks N., de Azambuja E., Berghoff A. S., Metellus P., Peters S., Hong Y. K., Winkler F., Schadendorf D., van den Bent M., Seoane J., Stahel R., Minniti G., Wesseling P., Weller M., Preusser M., Board E. E., clinicalguidelines@esmo.org E. G. C. E. a. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours // Ann Oncol. ‒ 2021. ‒ T. 32, № 11. ‒ C. 1332-1347.
137. Aukema T. S., Valdes Olmos R. A., Wouters M. W., Klop W. M., Kroon B. B., Vogel W. V., Nieweg O. E. Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases // Ann Surg Oncol. ‒ 2010. ‒ T. 17, № 10. ‒ C. 2773-8.
138. Aukema T. S., Olmos R. A., Korse C. M., Kroon B. B., Wouters M. W., Vogel W. V., Bonfrer J. M., Nieweg O. E. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up // Ann Surg Oncol. ‒ 2010. ‒ T. 17, № 6. ‒ C. 1657-61.
139. Tas F., Erturk K. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors // Melanoma Res. ‒ 2017.10.1097/CMR.0000000000000332.
140. Suh C. H., Jung S. C., Kim K. W., Pyo J. The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis // J Neurooncol. ‒ 2016. ‒ T. 129, № 2. ‒ C. 363-71.
141. Smith H. G., Bagwan I., Board R. E., Capper S., Coupland S. E., Glen J., Lalondrelle S., Mayberry A., Muneer A., Nugent K., Pathiraja P., Payne M., Peach H., Smith J., Westwell S., Wilson E., Rodwell S., Gore M., Turnbull N., Smith M. J. F. Ano-uro-genital mucosal melanoma UK national guidelines // Eur J Cancer. ‒ 2020. ‒ T. 135. ‒ C. 22-30.
142. Falch C., Stojadinovic A., Hann-von-Weyhern C., Protic M., Nissan A., Faries M. B., Daumer M., Bilchik A. J., Itzhak A., Brucher B. L. Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification // J Am Coll Surg. ‒ 2013. ‒ T. 217, № 2. ‒ C. 324-35.
143. Belli F., Gallino G. F., Lo Vullo S., Mariani L., Poiasina E., Leo E. Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano // Eur J Surg Oncol. ‒ 2009. ‒ T. 35, № 7. ‒ C. 757-62.
144. Wang S., Sun S., Liu X., Ge N., Wang G., Guo J., Liu W., Wang S. Endoscopic diagnosis of primary anorectal melanoma // Oncotarget. ‒ 2017. ‒ T. 8, № 30. ‒ C. 50133-50140.
145. Martling A., Holm T., Bremmer S., Lindholm J., Cedermark B., Blomqvist L. Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer // Br J Surg. ‒ 2003. ‒ T. 90, № 11. ‒ C. 1422-8.
146. Algebally A. M., Mohey N., Szmigielski W., Yousef R. R., Kohla S. The value of high-resolution MRI technique in patients with rectal carcinoma: pre-operative assessment of mesorectal fascia involvement, circumferential resection margin and local staging // Pol J Radiol. ‒ 2015. ‒ T. 80. ‒ C. 115-21.
147. Norenberg D., Sommer W. H., Thasler W., D'Haese J., Rentsch M., Kolben T., Schreyer A., Rist C., Reiser M., Armbruster M. Structured Reporting of Rectal Magnetic Resonance Imaging in Suspected Primary Rectal Cancer: Potential Benefits for Surgical Planning and Interdisciplinary Communication // Invest Radiol. ‒ 2017. ‒ T. 52, № 4. ‒ C. 232-239.
148. Battersby N. J., How P., Moran B., Stelzner S., West N. P., Branagan G., Strassburg J., Quirke P., Tekkis P., Pedersen B. G., Gudgeon M., Heald B., Brown G., Group M. I. S. Prospective Validation of a Low Rectal Cancer Magnetic Resonance Imaging Staging System and Development of a Local Recurrence Risk Stratification Model: The MERCURY II Study // Ann Surg. ‒ 2016. ‒ T. 263, № 4. ‒ C. 751-60.
149. Sahni V. A., Silveira P. C., Sainani N. I., Khorasani R. Impact of a Structured Report Template on the Quality of MRI Reports for Rectal Cancer Staging // AJR Am J Roentgenol. ‒ 2015. ‒ T. 205, № 3. ‒ C. 584-8.
150. Vliegen R. F., Beets G. L., von Meyenfeldt M. F., Kessels A. G., Lemaire E. E., van Engelshoven J. M., Beets-Tan R. G. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful? // Radiology. ‒ 2005. ‒ T. 234, № 1. ‒ C. 179-88.
151. Uffman J. C., Tumin D., Raman V., Thung A., Adler B., Tobias J. D. MRI Utilization and the Associated Use of Sedation and Anesthesia in a Pediatric ACO // J Am Coll Radiol. ‒ 2017. ‒ T. 14, № 7. ‒ C. 924-930.
152. Schlatter J., Kabiche S., Sellier N., Fontan J. E. Oral pentobarbital suspension for children sedation during MR imaging // Ann Pharm Fr. ‒ 2018. ‒ T. 76, № 4. ‒ C. 286-290.
153. Nagoshi M., Reddy S., Bell M., Cresencia A., Margolis R., Wetzel R., Ross P. Low-dose dexmedetomidine as an adjuvant to propofol infusion for children in MRI: A double-cohort study // Paediatr Anaesth. ‒ 2018. ‒ T. 28, № 7. ‒ C. 639-646.
154. McGuirt D. Alternatives to Sedation and General Anesthesia in Pediatric Magnetic Resonance Imaging: A Literature Review // Radiol Technol. ‒ 2016. ‒ T. 88, № 1. ‒ C. 18-26.